Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | BTK | Q06187 | 4/20 | 0.35 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24324680 | 0.91 | NPC1 (0.35) | BTKKMT2AGRM5KDM4ECYP3A4 | |
| SCHEMBL21344830 | 0.89 | FAAH (0.41) | FAAHTRPV1FNTAFNTBKMT2A | |
| SCHEMBL22992194 | 0.88 | TRPV1 (0.36) | TRPV1KMT2AALDH1A1 | |
| SCHEMBL22942059 | 0.86 | RAB9A (0.35) | KMT2AKDM4ECYP3A4TSHRALDH1A1 | |
| SCHEMBL22942017 | 0.86 | NPC1 (0.41) | GRM5TSHRALDH1A1 | |
| SCHEMBL21344636 | 0.85 | L3MBTL1 (0.44) | CYP3A4ALDH1A1CYP2D6CYP2C19HSD17B10 | |
| SCHEMBL21343728 | 0.84 | CYP3A4 (0.31) | KMT2ACYP3A4 | |
| SCHEMBL21344667 | 0.83 | SMN1; SMN2 (0.42) | FAAHCYP3A4TSHRCYP2D6 | |
| SCHEMBL22992236 | 0.82 | NAMPT (0.38) | FNTAFNTBKDM4ETSHRALDH1A1 | |
| SCHEMBL21344248 | 0.82 | HIF1A (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043599-B2 | Herbicidal compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2024-07-23 | — | — | US | disclosed |
| EP-3762378-B1 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2022-05-18 | — | — | EP | disclosed |
| US-20210047274-A1 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047274-A1 | HERBICIDAL COMPOUNDS | DDT, CBR3, GLRX3 | FAAH 750/4885TRPV1 2779/4885BTK 3741/4885 |
| US-12043599-B2 | Herbicidal compounds | DDT, CBR3, GLRX3 | FAAH 750/4885TRPV1 2779/4885BTK 3741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.